Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 2
1983 3
1984 5
1985 2
1986 2
1987 5
1988 4
1989 5
1990 5
1991 7
1992 3
1993 6
1994 5
1995 5
1996 6
1997 4
1998 10
1999 13
2000 9
2001 4
2002 7
2003 6
2004 4
2005 6
2006 7
2007 7
2008 10
2009 14
2010 7
2011 5
2012 4
2013 6
2014 5
2015 8
2016 5
2017 3
2018 5
2019 2
2020 4
2021 5
2022 6
2023 2
2024 3
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

227 results

Results by year

Filters applied: . Clear all
Page 1
14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia.
Di Giacomo D, La Starza R, Gorello P, Pellanera F, Kalender Atak Z, De Keersmaecker K, Pierini V, Harrison CJ, Arniani S, Moretti M, Testoni N, De Santis G, Roti G, Matteucci C, Bassan R, Vandenberghe P, Aerts S, Cools J, Bornhauser B, Bourquin JP, Piazza R, Mecucci C. Di Giacomo D, et al. Among authors: testoni n. Blood. 2021 Sep 2;138(9):773-784. doi: 10.1182/blood.2020010510. Blood. 2021. PMID: 33876209 Free PMC article. Clinical Trial.
High level of circulating cell-free tumor DNA at diagnosis correlates with disease spreading and defines multiple myeloma patients with poor prognosis.
Martello M, Solli V, Mazzocchetti G, Solimando AG, Bezzi D, Taurisano B, Kanapari A, Poletti A, Borsi E, Armuzzi S, Vigliotta I, Pistis I, Desantis V, Marzocchi G, Rizzello I, Pantani L, Mancuso K, Tacchetti P, Testoni N, Nanni C, Zamagni E, Cavo M, Terragna C. Martello M, et al. Among authors: testoni n. Blood Cancer J. 2024 Nov 28;14(1):208. doi: 10.1038/s41408-024-01185-6. Blood Cancer J. 2024. PMID: 39609411 Free PMC article.
Circulating Multiple Myeloma Cells (CMMCs) as Prognostic and Predictive Markers in Multiple Myeloma and Smouldering MM Patients.
Vigliotta I, Solli V, Armuzzi S, Martello M, Poletti A, Taurisano B, Pistis I, Mazzocchetti G, Borsi E, Pantani L, Marzocchi G, Testoni N, Zamagni E, Terracciano M, Tononi P, Garonzi M, Ferrarini A, Manaresi N, Cavo M, Terragna C. Vigliotta I, et al. Among authors: testoni n. Cancers (Basel). 2024 Aug 23;16(17):2929. doi: 10.3390/cancers16172929. Cancers (Basel). 2024. PMID: 39272787 Free PMC article.
Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic responders.
Bonifazi F, de Vivo A, Rosti G, Guilhot F, Guilhot J, Trabacchi E, Hehlmann R, Hochhaus A, Shepherd PC, Steegmann JL, Kluin-Nelemans HC, Thaler J, Simonsson B, Louwagie A, Reiffers J, Mahon FX, Montefusco E, Alimena G, Hasford J, Richards S, Saglio G, Testoni N, Martinelli G, Tura S, Baccarani M; Europena Study Group on Interferon in Chronic Myeloid Leukemia; Italian Cooperative Study Group on CML; France Intergroup of CML; German CML Study Group; UK Medical Research Council Working Party on CML; Spanish CML Study Group; Australian CML Study Group; Swedish CML Study Group. Bonifazi F, et al. Among authors: testoni n. Blood. 2001 Nov 15;98(10):3074-81. doi: 10.1182/blood.v98.10.3074. Blood. 2001. PMID: 11698293 Free article. Review.
The GNAS1 gene in myelodysplastic syndromes (MDS).
Di Giacomo D, Lema Fernandez AG, Pierini T, Crescenzi B, Brandimarte L, Matteucci C, Testoni N, Mecucci C. Di Giacomo D, et al. Among authors: testoni n. Leuk Res. 2014 Jul;38(7):804-7. doi: 10.1016/j.leukres.2014.03.017. Epub 2014 Mar 29. Leuk Res. 2014. PMID: 24795070
Unique molecular assay (UMA): a next-generation sequencing targeted panel for efficient and comprehensive genomic profiling and risk stratification of multiple myeloma.
Poletti A, Taurisano B, Mazzocchetti G, Lionetti M, Martello M, Vuong VM, Solli V, Marzocchi G, Maeda A, Vigliotta I, Borsi E, Armuzzi S, Pistis I, Marella A, Fabris S, Tacchetti P, Mancuso K, Rizzello I, Pantani L, Testoni N, Cavo M, Zamagni E, Bolli N, Terragna C. Poletti A, et al. Among authors: testoni n. Haematologica. 2025 Oct 1;110(10):2436-2450. doi: 10.3324/haematol.2025.287559. Epub 2025 May 15. Haematologica. 2025. PMID: 40371906 Free PMC article.
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib.
Castagnetti F, Gugliotta G, Breccia M, Stagno F, Iurlo A, Albano F, Abruzzese E, Martino B, Levato L, Intermesoli T, Pregno P, Rossi G, Gherlinzoni F, Leoni P, Cavazzini F, Venturi C, Soverini S, Testoni N, Alimena G, Cavo M, Martinelli G, Pane F, Saglio G, Rosti G, Baccarani M; GIMEMA CML Working Party. Castagnetti F, et al. Among authors: testoni n. Leukemia. 2015 Sep;29(9):1823-31. doi: 10.1038/leu.2015.152. Epub 2015 Jun 19. Leukemia. 2015. PMID: 26088952 Clinical Trial.
Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myeloma.
Martello M, Poletti A, Borsi E, Solli V, Dozza L, Barbato S, Zamagni E, Tacchetti P, Pantani L, Mancuso K, Vigliotta I, Rizzello I, Rocchi S, Armuzzi S, Testoni N, Marzocchi G, Martinelli G, Cavo M, Terragna C. Martello M, et al. Among authors: testoni n. Blood Cancer J. 2022 Jan 26;12(1):15. doi: 10.1038/s41408-022-00610-y. Blood Cancer J. 2022. PMID: 35082295 Free PMC article.
227 results